Citi Downgrades Relypsa, Inc. (RLYP) to Neutral

Go back to Citi Downgrades Relypsa, Inc. (RLYP) to Neutral

Galenica to acquire Relypsa to strengthen its Business unit Vifor Pharma

July 21, 2016 1:02 AM EDT

Vifor Pharma Ltd. / Galenica to acquire Relypsa to strengthen its Business unit Vifor Pharma . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Galenica and Relypsa announce agreement for Galenica to acquire Relypsa. Acquisition strengthens Galenica's Business unit, Vifor Pharma - an important step towards becoming an independent specialty pharma company... More